Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FysioDanmark Holbæk, Autoriseret Fysioterapeuter ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   1.2% 1.3% 1.2% 1.2% 2.4% 1.3% 7.9% 7.0%   Credit score (0-100)   84 82 81 80 63 79 31 34   Credit rating   A A A A BBB A BB BBB   Credit limit (kDKK)   65.7 48.7 68.0 65.9 0.0 71.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,809 4,820 4,936 5,990 5,767 7,779 0.0 0.0   EBITDA   1,083 1,040 865 815 585 987 0.0 0.0   EBIT   692 647 459 406 85.0 442 0.0 0.0   Pre-tax profit (PTP)   666.0 638.0 446.0 400.0 71.0 421.4 0.0 0.0   Net earnings   519.0 497.0 345.0 309.0 50.0 324.3 0.0 0.0   Pre-tax profit without non-rec. items   666 638 446 400 71.0 421 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   553 390 239 691 1,045 797 0.0 0.0   Shareholders equity total   1,341 1,629 1,757 2,066 2,116 2,322 2,072 2,072   Interest-bearing liabilities   1,065 464 638 743 1,231 344 0.0 0.0   Balance sheet total (assets)   3,146 2,696 3,619 3,893 4,444 4,093 2,072 2,072   Net Debt   922 461 -584 739 951 105 -959 -959     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,809 4,820 4,936 5,990 5,767 7,779 0.0 0.0   Gross profit growth   3.5% 0.2% 2.4% 21.4% -3.7% 34.9% -100.0% 0.0%   Employees   8 8 9 12 12 14 0 0   Employee growth %   0.0% 0.0% 12.5% 33.3% 0.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,146 2,696 3,619 3,893 4,444 4,093 2,072 2,072   Balance sheet change%   -5.0% -14.3% 34.2% 7.6% 14.2% -7.9% -49.4% 0.0%   Added value   1,083.0 1,040.0 865.0 815.0 494.0 987.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -783 -761 -762 706 -443 -1,090 -797 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.4% 13.4% 9.3% 6.8% 1.5% 5.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   21.9% 22.7% 14.7% 11.0% 2.2% 10.6% 0.0% 0.0%   ROI %   26.8% 28.1% 19.7% 15.2% 2.8% 14.3% 0.0% 0.0%   ROE %   40.5% 33.5% 20.4% 16.2% 2.4% 14.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   50.6% 69.7% 55.5% 53.1% 47.6% 57.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   85.1% 44.3% -67.5% 90.7% 162.6% 10.6% 0.0% 0.0%   Gearing %   79.4% 28.5% 36.3% 36.0% 58.2% 14.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.1% 3.4% 3.3% 2.0% 1.9% 3.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 1.0 1.3 0.6 0.6 0.9 0.0 0.0   Current Ratio   0.7 1.1 1.3 0.6 0.6 1.0 0.0 0.0   Cash and cash equivalent   143.0 3.0 1,222.0 4.0 280.0 238.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -365.0 49.0 473.0 -595.0 -770.0 -27.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   135 130 96 68 41 71 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   135 130 96 68 49 71 0 0   EBIT / employee   87 81 51 34 7 32 0 0   Net earnings / employee   65 62 38 26 4 23 0 0